Bradykinin receptor B1
Bradykinin receptor B1 is a protein that in humans is encoded by the BDKRB1 gene. It is a member of the G protein-coupled receptor family. The Bradykinin receptor B1 is a receptor for bradykinin. The receptor is coupled to G proteins that stimulate a phosphatidylinositol-calcium second messenger system.
Function[edit]
The Bradykinin receptor B1 is part of the kinin-kallikrein system which is involved in inflammation, pain, and other processes. Bradykinin, a 9 amino acid peptide, is a potent vasodilator that increases capillary permeability, stimulates the release of prostaglandins, causes smooth muscle contraction, and induces pain. The B1 receptor is expressed only after tissue injury or inflammation, and its signaling may contribute to inflammation and pain.
Clinical significance[edit]
The Bradykinin receptor B1 has been implicated in a variety of disease states, including diabetes, inflammation, and cancer. In diabetes, the receptor is upregulated and contributes to the vascular complications of the disease. In inflammation, the receptor is induced and contributes to the inflammatory response. In cancer, the receptor is overexpressed in certain types of tumors and may contribute to tumor growth and metastasis.
See also[edit]
References[edit]
<references />
| Human Proteins | ||||||||
|---|---|---|---|---|---|---|---|---|
This human proteins-related article is a stub. You can help WikiMD by expanding it.
|
| Inflammation | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Diabetes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Overview of tumors, cancer and oncology (C00–D48, 140–239) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
